长链多不饱和脂肪酸在重性抑郁障碍与自杀风险神经生物学中的作用
本文综述长链多不饱和脂肪酸(LC-PUFA)的神经生物学机制及其在重性抑郁与自杀风险中的意义。LC-PUFA 的膳食摄入与合成酶遗传变异影响其体内水平,其失衡通过细胞信号、炎症与生物能量学三个领域参与精神障碍病理。作者指出这些机制尚未充分转化为人类临床研究,未来需整合机制与临床结局以识别最可能对 n-3 LC-PUFA 补充剂应答的抑郁个体。
要点
- LC-PUFA 失衡与重性抑郁及自杀风险相关,膳食摄入与合成酶遗传变异影响其水平。
- n-3 与 n-6 LC-PUFA 平衡深刻影响炎症,n-3 产物参与炎症消退并抑制小胶质细胞活化。
- 线粒体内膜 n-3 LC-PUFA 影响氧化应激并具神经保护作用,但临床转化研究仍不足。
核心结论
- LC-PUFA 通过细胞信号、炎症与生物能量学三个领域影响脑功能,其失衡与重性抑郁和自杀风险相关。
- 现有 LC-PUFA 生物学机制知识尚未充分转化为人类临床效应研究。
- 未来整合神经生物学机制与临床结局的研究,可能有助于识别最可能对 n-3 LC-PUFA 补充剂应答的抑郁个体。
研究设计与样本
- 本文为综述,检索范围与纳入文献数量原文未报告。
主要发现
- LC-PUFA 的神经生物学效应源于其长度与双键构型等理化特性,n-3 与 n-6 LC-PUFA 功能存在差异。
- 作为脂双层主要成分,LC-PUFA 决定细胞膜黏度与有序性,影响脂筏及单胺能受体和转运体等膜结合蛋白的调控。
- n-6 LC-PUFA 代谢产物(类花生酸)一般促炎,n-3 LC-PUFA 代谢产物(docosanoids)参与炎症消退。
- n-3 LC-PUFA 抑制小胶质细胞活化及随后的促炎级联反应。
- 线粒体内膜 n-3 LC-PUFA 抑制活性氧(ROS)产生并清除 ROS,具神经保护益处。
临床怎么用
- 综述提示 n-3 LC-PUFA 补充剂对抑郁个体的疗效可能需结合机制特征筛选应答人群,但尚缺乏可用的临床筛选标准。
局限性
- 原文指出 LC-PUFA 生物学机制知识尚未被充分用于人类临床效应转化研究,机制研究与临床结局的整合仍不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Long-chain polyunsaturated fatty acids (LC-PUFAs) are obtained from diet or derived from essential shorter-chain fatty acids, and are crucial for brain development and functioning. Fundamentally, LC-PUFAs' neurobiological effects derive from their physicochemical characteristics, including length and double bond configuration, which differentiate LC-PUFA species and give rise to functional differences between n(omega)-3 and n-6 LC-PUFAs. LC-PUFA imbalances are implicated in psychiatric disorders, including major depression and suicide risk. Dietary intake and genetic variants in enzymes involved in biosynthesis of LC-PUFAs from shorter chain fatty acids influence LC-PUFA status. Domains impacted by LC-PUFAs include 1) cell signaling, 2) inflammation, and 3) bioenergetics. 1) As major constituents of lipid bilayers, LC-PUFAs are determinants of cell membrane properties of viscosity and order, affecting lipid rafts, which play a role in regulation of membrane-bound proteins involved in cell-cell signaling, including monoaminergic receptors and transporters. 2) The n-3:n-6 LC-PUFA balance profoundly influences inflammation. Generally, metabolic products of n-6 LC-PUFAs (eicosanoids) are pro-inflammatory, while those of n-3 LC-PUFAs (docosanoids) participate in the resolution of inflammation. Additionally, n-3 LC-PUFAs suppress microglial activation and the ensuing proinflammatory cascade. 3) N-3 LC-PUFAs in the inner mitochondrial membrane affect oxidative stress, suppressing production of and scavenging reactive oxygen species (ROS), with neuroprotective benefits. Until now, this wealth of knowledge about LC-PUFA biomechanisms has not been adequately tapped to develop translational studies of LC-PUFA clinical effects in humans. Future studies integrating neurobiological mechanisms with clinical outcomes may suggest ways to identify depressed individuals most likely to respond to n-3 LC-PUFA supplementation, and mechanistic research may generate new treatment strategies.
引用
- Sublette ME, Daray FM, Ganança L, et al. The role of polyunsaturated fatty acids in the neurobiology of major depressive disorder and suicide risk. Mol Psychiatry. 2023. PMID: 37993501. doi:10.1038/s41380-023-02322-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。